Vibration therapy for Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cancer+3 MoreVibration therapy - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing if a 3-minute daily hand-held vibration therapy can reduce the severity of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in the hands and improve quality of life.

Eligible Conditions
  • Chemotherapy Toxicity
  • Cancer
  • Neuropathy
  • Chemotherapy-Induced Nephropathy

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 2 Secondary · Reporting Duration: recruitment period (up to 1 year after study starts)

4 weeks
Acceptability of Intervention- percentage of patients who answer agree on acceptability form
Feasibility of compliance- percentage of vibration therapy sessions completed
Week 4
Change in the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy Induced Peripheral Neuropathy twenty-item scale (CIPN20) scores
Week 8
Change in CIPN related Quality of Life via the Chemotherapy Induced Peripheral Neuropathy Quality of Life Scale
Week 8
Change in CIPN Severity via the CIPN20 questionnaire scores
Year 1
Feasibility of recruitment- percentage of patients who agree to participate in the study after screening

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Vibration Therapy
1 of 1

Experimental Treatment

16 Total Participants · 1 Treatment Group

Primary Treatment: Vibration therapy · No Placebo Group · N/A

Vibration Therapy
Device
Experimental Group · 1 Intervention: Vibration therapy · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vibration therapy
2011
N/A
~50

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: recruitment period (up to 1 year after study starts)

Who is running the clinical trial?

Indiana UniversityLead Sponsor
877 Previous Clinical Trials
759,539 Total Patients Enrolled
Indiana Clinical and Translational Sciences InstituteOTHER
18 Previous Clinical Trials
5,460 Total Patients Enrolled
Erin Newton, MD4.796 ReviewsPrincipal Investigator - Indiana University
Medical School - Aga Khan University Medical College, Bachelor of Medicine, Bachelor of Surgery
West Virginia University (Residency)
1 Previous Clinical Trials
5Patient Review
The office staff were lovely and I didn't have to wait long before seeing the doctor. Dr. Sher was so helpful and answered all my questions thoroughly.

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have non-metastatic cancer.
Continue to display evidence of sensory CIPN in the hands rated at a Grade ≥ 2 according to the NCI-CTC-AE, Version 5.0, ≥ 60 days post-chemotherapy.
You are 18 years or older at enrollment.\n
You are able to provide informed consent and HIPAA authorization.
You agree to return to the clinic for the required study related measurements at the specified intervals.